Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time Tradegate - 08/25 10:03:30 am
10.384 EUR   -0.44%
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new Germa..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital inc..
2015 CYTOTOOLS : DermaPro retains its potential
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
08/18/2016 08/19/2016 08/22/2016 08/23/2016 08/24/2016 Date
10.415(c) 10.51(c) 10.31(c) 10.4(c) 10.43(c) Last
50 1 803 2 634 2 519 396 Volume
+0.58% +0.91% -1.90% +0.87% +0.29% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -2,60 M
Net income 2015 -2,60 M
Finance 2015 0,20 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,70 M
Net income 2016 -1,70 M
Finance 2016 2,30 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales2015 13,8x
EV / Sales2016 7,14x
Capitalization 20,9 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which engages in developing therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
Sector
Biotechnology & Medical Research
Calendar
08/29 | 10:00amShareholder meeting
More about the company
Latest news on CYTOTOOLS AG
07/29 DGAP-NEWS : Wechsel im Aufsichtsrat der CytoTools AG - Herr Dr. Tober legt aus..
05/23 DGAP-NEWS : CytoTools AG: Resultate aus der Phase II/III Studie zur Behandlung d..
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new German manufactur..
04/22 DGAP-NEWS : DermaTools Biotech GmbH identifiziert neuen Hersteller für Wirkstoff..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
02/03 CYTOTOOLS : stärkt das Tochterunternehmen DermaTools Biotech GmbH durch Kapitale..
01/26 CYTOTOOLS : klärt die Ursachen der zu geringen Wirkstoffkonzentration auf, die z..
2015 CYTOTOOLS : DermaPro retains its potential
2015 CYTOTOOLS : berichtet: Der Wirkstoff DermaPro(R) behält sein Potential (DGAP New..
2015 CYTOTOOLS : berichtet über Ergebnisse der europäischen klinischen Studie Phase I..
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 €
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark-Andre Freyberg CEO & Head-Investor Relations
Manfred May Chairman-Supervisory Board
Dirk Kaiser Chief Research Officer
Markus H. Weissbach Chief Medical Officer
Dieter Tober Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG0.00%24
AMGEN, INC.5.24%127 850
GILEAD SCIENCES, INC.-20.45%106 233
CELGENE CORPORATION-7.65%85 728
REGENERON PHARMACEUTIC..-25.35%42 671
VERTEX PHARMACEUTICALS..-23.14%23 963
More Results